This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Tyme Technologies Gestion
Gestion contrôle des critères 3/4
Informations clés
Richie Cunningham
Directeur général
US$1.3m
Rémunération totale
| Pourcentage du salaire du PDG | 42.0% |
| Durée du mandat du directeur général | 1.8yrs |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | 2.7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 6.1yrs |
Mises à jour récentes de la gestion
Recent updates
Syros, Tyme Technologies jump more than 20% after hours as shareholders approve merger
Sep 15We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth
Aug 05
TYME stock surges on merger agreement and Syros Pharmaceuticals
Jul 05Tyme Technologies: Net-Net Biopharma Exploring Strategic Alternatives
May 26We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth
Mar 19Tyme Technologies Offers Incredible Risk-Reward
Dec 07Here's Why We're Not Too Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Nov 19Tyme Technologies: The Market Missed The Bullish Memo
Aug 27We're Not Very Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Rate
Jul 19Tyme Technologies reports FY results
Jun 10Tyme Technologies: Recent Sell-Off Provides Opportunity To Buy At A Discount
May 29Here's Why We're Watching Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Mar 26Have Tyme Technologies, Inc. (NASDAQ:TYME) Insiders Been Selling Their Stock?
Feb 19
Tyme falls after equity offer as quarterly data indicate liquidity pressure
Feb 04Tyme stock granted U.S. patent claims for using TYME-19 to treat COVID-19 infections
Feb 03Do Institutions Own Tyme Technologies, Inc. (NASDAQ:TYME) Shares?
Feb 02Revisiting Tyme Technologies
Dec 17Have Insiders Sold Tyme Technologies, Inc. (NASDAQ:TYME) Shares Recently?
Dec 16Is Tyme Technologies (NASDAQ:TYME) In A Good Position To Invest In Growth?
Dec 09Tyme Technologies names new finance chief
Nov 30Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$24m |
| Mar 31 2022 | US$1m | US$564k | -US$24m |
| Dec 31 2021 | n/a | n/a | -US$24m |
| Sep 30 2021 | n/a | n/a | -US$25m |
| Jun 30 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | US$2m | US$194k | -US$29m |
Rémunération vs marché: Richie's total compensation ($USD1.34M) is above average for companies of similar size in the US market ($USD765.87K).
Rémunération et revenus: Richie's compensation has been consistent with company performance over the past year.
PDG
Richie Cunningham (51 yo)
1.8yrs
Titularisation
US$1,344,080
Compensation
Mr. Richard Cunningham, also known as Richie, serves as Chief Executive Officer and Director at Tyme Technologies, Inc. since November 23, 2020. Mr. Cunningham had been the Chief Executive Officer and Pres...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$1.34m | pas de données | |
| Co-Founder & Director | 9.2yrs | US$2.60m | 11.63% $ 6.2m | |
| Chief Financial Officer | 1.3yrs | US$1.29m | 0.0058% $ 3.1k | |
| Chief Legal Officer & Secretary | 4yrs | US$1.19m | 0.061% $ 32.7k | |
| Chief Business Officer | 3.5yrs | US$858.79k | pas de données | |
| Acting Chief Medical Officer | 1.4yrs | pas de données | 0.0057% $ 3.1k |
2.7yrs
Durée moyenne de l'emploi
58yo
Âge moyen
Gestion expérimentée: TYME's management team is considered experienced (2.7 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$1.34m | pas de données | |
| Co-Founder & Director | 7.5yrs | US$2.60m | 11.63% $ 6.2m | |
| Independent Director | 7.5yrs | US$138.73k | 0.0034% $ 1.8k | |
| Independent Director | 4.3yrs | US$146.99k | pas de données | |
| Independent Chairman | 3.9yrs | US$166.34k | 0.064% $ 34.2k | |
| Independent Director | 5.5yrs | US$148.24k | 0.058% $ 31.1k | |
| Independent Director & Member of Medical Advisory Board | 7.5yrs | US$122.87k | 0.0034% $ 1.8k | |
| Member of Medical Advisory Board | 6.7yrs | pas de données | pas de données | |
| Member of Medical Advisory Board | no data | pas de données | pas de données | |
| Member of Medical Advisory Board | no data | pas de données | pas de données | |
| Member of Medical Advisory Board | no data | pas de données | pas de données | |
| Member of Medical Advisory Board | no data | pas de données | pas de données |
6.1yrs
Durée moyenne de l'emploi
65yo
Âge moyen
Conseil d'administration expérimenté: TYME's board of directors are considered experienced (6.1 years average tenure).